Lucintel Forecasts The Global Microbiome Therapeutics Market To Grow With A Cagr Of 35.3% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 6936
Comment this article

According to a market report by Lucintel, the future of the global microbiome therapeutics market looks promising with opportunities in the C. difficile, crohn’s disease, inflammatory bowel disease, and diabetes markets. The global microbiome therapeutics market is expected to grow with a CAGR of 35.3% from 2025 to 2031. The major drivers for this market are the increasing research into gut health therapies, the rising prevalence of chronic immune disorders, and the growing investment in microbiome based drugs.
A more than 150-page report to understand trends, opportunity and forecast in global microbiome therapeutics market to 2031 by type (FMT and microbiome drugs), application (C. difficile, crohn’s disease, inflammatory bowel disease, diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, FMT is expected to witness higher growth over the forecast period.
Within the application category, C. difficile is expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest ...
... growth over the forecast period.
Download sample by clicking on microbiome therapeutics market.
OpenBiome, Seres Therapeutics Inc., 4D Pharma plc., Locus Biosciences, Inc., Enterome SA, Finch Therapeutics Group, Inc., Intralytix, Inc., Microbiotica, Second Genome, Rebiotix Inc. are the major suppliers in the microbiome therapeutics market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Botox Injection Market
Craniomaxillofacial Bone Plate System Market
Deep RF Microneedling Market
Dental Loupe Market
Dialysate Calibrator Market